?Essential? phospholipids versus nicotinic acid in the treatment of patients with type IIb hyperlipoproteinemia and ischemic heart disease
- 1 December 1995
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cardiovascular Drugs and Therapy
- Vol. 9 (6), 779-784
- https://doi.org/10.1007/bf00879871
Abstract
In patients with moderate, dietary noncorrigible hyperlipoproteinemia type IIb and ischemic heart disease, treatment with nicotinic acid is limited by the side effects of the drug. In 100 patients, 6-month treatment with nicotinic acid (n=50) or “essential” phospholipids (EPL); Lipostabil®, manufacturer: Rhône-Poulenc Rorer) (n=50) indicated comparable efficacy for both substances: Significant (p<.001) reductions of serum total cholesterol, low-density lipoprotein (LDL) cholesterol, and triglyceride values were similar in both groups, while nicotinic acid increased high-density lipoprotein (HDL) cholesterol significantly (p<.01) better than Lipostabil. A detailed analysis of ultracentrifugal lipoprotein profiles, hydroperoxide concentrations in LDL, and cholesterol-accepting properties of HDL in a small number of Lipostabil- and nicotinic acid-treated patients revealed favorable shifts in the lipoprotein profile, significant (p<.05) reductions of LDL hydroperoxides, and favorable increases of the most antiatherogenic HDL2b subfraction only in the Lipostabil-treated group. Clinically, both medications reduced the intensity and number of angina pectoris attacks per week (p<.05), but only Lipostabil-treated patients significantly (p<.05) increased their working capacity in the veloergometric test. Since in the nicotinic acid-treated group dropouts (nine patients, eight related to the drug) and side effects [14] exceeded those in the Lipostabil-treated group (two dropouts not related to the drug, no side effects), it is suggested that Lipostabil is a preferable alternative in the treatment of patients with moderate, dietary noncorrigible hyperlipoproteinemia IIb and ischemic heart disease.Keywords
This publication has 7 references indexed in Scilit:
- Influence of dietary egg and soybean phospholipids and triacylglycerols on human serum lipoproteinsLipids, 1993
- Niacin revisited. A randomized, controlled trial of wax-matrix sustained-release niacin in hypercholesterolemiaArchives of Internal Medicine, 1991
- Niacin RevisitedArchives of Internal Medicine, 1991
- A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent.Journal of Lipid Research, 1989
- Rapid preparative isolation of concentrated low density lipoproteins and of lipoprotein-deficient serum using vertical rotor gradient ultracentrifugation.Journal of Lipid Research, 1985
- Characterization of human high-density lipoproteins by gradient gel electrophoresisBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1981